Mireille E. Schnitzer

Collider bias undermines our understanding of COVID-19 disease risk and severity

Macrophages in immunoregulation and therapeutics

Systemic sclerosis

Multimodal biomedical AI

Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)

Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy

Systemic sclerosis

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Data-driven Confounder Selection via Markov and Bayesian Networks

Hypertensive Disorders of Pregnancy

Potential Outcome and Directed Acyclic Graph Approaches to Causality: Relevance for Empirical Practice in Economics

Educational Note: Paradoxical collider effect in the analysis of non-communicable disease epidemiological data: a reproducible illustration and web application

Variable Selection for Confounder Control, Flexible Modeling and Collaborative Targeted Minimum Loss-Based Estimation in Causal Inference

Disability in Systemic Sclerosis — A Longitudinal Observational Study

Recurrent pre-eclampsia and subsequent cardiovascular risk